Neuroallianz
Research Areas
At a Glance
- Status: Active Consortium
- Year Launched: 2009
- Initiating Organization: German Federal Ministry for Education and Research (BMBF)
- Initiator Type: Government
- Disease focus:
Alzheimer's Disease, Epilepsy, Parkinson's Disease - Location: Europe
Abstract
The Neuroallianz consortium consists of strategic research partnerships. Its focus is on therapeutic and diagnostic approaches to neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, or epilepsy derived from research on developing medicines. Neuroallianz focuses on the implementation of projects in the following areas: therapeutic projects, diagnostic projects, and support projects.
Mission
Neuroallianz has designed a new type of strategic partnership model, in which various academic institutions and companies work on a range of innovative diagnostic and therapeutic research projects. Its aim is to selectively and efficiently transform research into tangible benefits for patients. Its focus is on the diagnosis and treatment of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, or epilepsy.
Consortium History
2009-2015: Project duration
Structure & Governance
The project team consist of project manager, deputy project manager, and project team members who implement the project in accordance with the agreed upon project plan. The project manager and the project team members work in a collaborative, open, and transparent manner.
The Steering Committee coordinates, controls, and directs the progress of the Neuroallianz project portfolio, taking into account the BMBF requirements and strategic recommendations of the Strategic Advisory Board.
The Strategic Advisory Board consists of members with outstanding experience in industrial enterprises and/or academic institutions. Its mission is to provide strategic and scientific guidance for the research program.
A close and open cooperation between the partners ensures a successful processing of Neuroallianz projects. The consortium manager is responsible for coordination and management of the consortium members and their external representation.
The scientific coordinator of the University of Bonn supports the consortium manager in coordinating Neuroallianz activities at the University of Bonn.
Financing
The consortium budget is €40 million.
Links/Social Media Feed
|
Homepage |
Points of Contact
email: Neuroallianz-helpdesk@fraunhofer.de
Service provider for its own and third-party information partners of the Neuroallianz:
UCB Pharma GmbH
Alfred-Nobel-Straße 10
40789 Monheim
Managing Director: Peter Mitterhofer
Technical Contact
Stephan Spring Stubbe
phone: +49 (0) 2241 14 2337
email: stephan.springstubbe@scai.fraunhofer.de
Sponsors & Partners
|
Charite–University Berlin |
|
Cube Biotech GmbH |
|
Fraunhofer Society for the Promotion of Applied Research |
|
Helmholtz-Zentrum Dresden-Rossendorf |
|
IBL International GmbH |
|
Immunogenetics AG |
|
Life and Brain GmbH |
|
Pharmacelsus GmbH |
|
Piramal Imaging GmbH |
|
Ratiopharm GmbH |
|
Research Center Julich |
|
ROTOP Pharmaceuticals AG |
|
UCB Pharma GmbH |
|
University of Bonn |
|
University of Essen |
|
University of Gottingen |
|
University of Tubingen |
|
Young Diagnostics GmbH |